SAN FRANCISCO, June 15, 2016 /PRNewswire/ -- The global smart syringes market is expected to reach USD 10.2 billion in 2024, according to a new report by Grand View Research, Inc. In 2015, some key factors driving the market include the rise in the patient population, the increasing number of needle stick injuries, and the spread of diseases due to unhygienic injection practices.
The injection practices and healthcare delivery standards are not uniform across the globe. The use of disposable syringes has been strongly advocated by various healthcare organizations across different countries; however, adherence to the patient safety guidelines is not adequately implemented in the LMIC (Low and Middle Income Countries).
As per the WHO records, the re-usage of syringes has boosted the infection cases of Ebola, malaria, Marburg virus, HIV, hepatitis, and other diseases in LMIC; these countries have been suffering with a huge infectious diseases burden due to the high transmission rates of blood-borne virus infections. Increasing awareness regarding the usage of smart syringes with safety mechanisms amongst the patients and the healthcare providers is anticipated to fuel the expansion of the smart syringes market over the forecast period.
Access full research report at: http://www.grandviewresearch.com/industry-analysis/smart-syringes-market
As per the data published by the U.S. Occupational Safety and Health Administration (OSHA), nearly 5.6 million workers in the healthcare sector are at a high risk of occupational exposure to blood-borne pathogens, mainly on account of needle stick injuries and other metal injuries. The data also indicates that on an average 1,000 injuries occur per day in the U.S. hospitals, which translates to 385,000 needle stick and other injuries per year.
Hence, in order to improve the healthcare outcomes and reduce the burden of infections, the healthcare practitioners and hospitals are expected to adopt the usage of smart syringes, which would significantly boost the smart syringes market over the forecast period.
- Smart Syringes Product Outlook, (USD Million, 2013 – 2024)
- Auto-disable syringes
- Active safety syringes
- Passive safety syringes
- Smart Syringes Application Outlook, (USD Million, 2013 – 2024)
- Drug delivery
- Blood specimen collection
- Smart Syringes End-Use Outlook, (USD Million, 2013 – 2024)
- Hospitals and HMOs
- Diabetic patients
- Family practices (Physicians)
- Smart Syringes Regional Outlook, (USD Million, 2013 – 2024)
- North America
- Asia Pacific
- Latin America
- South Africa
- North America
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/smart-syringes-market-size-to-reach-usd-102-billion-by-2024-grand-view-research-inc-300284935.html
SOURCE Grand View Research, Inc.